Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Donor Lymphocyte Infusion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00966810
What this trial is testing

Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion

Who this might be right for
Philadelphia Chromosome-positive Chronic Myelocytic Leukemia
Rambam Health Care Campus 40
Testing effectiveness (Phase 2)Looking for participantsNCT05943067
What this trial is testing

CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT

Who this might be right for
Hematologic Malignancy
University Hospital Tuebingen 60
Testing effectiveness (Phase 2)UnknownNCT06141304
What this trial is testing

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

Who this might be right for
Relapsed Adult ALLRelapsed Adult AML
The First Hospital of Jilin University 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT03597321
What this trial is testing

Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Institut Paoli-Calmettes 124
Testing effectiveness (Phase 2)Study completedNCT05009719
What this trial is testing

Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy

Who this might be right for
Hematologic Malignancy
St. Petersburg State Pavlov Medical University 50
Early research (Phase 1)UnknownNCT02779439
What this trial is testing

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation

Who this might be right for
CMV InfectionEBVAdenovirus
University of Sydney 25
Testing effectiveness (Phase 2)Study completedNCT04620681
What this trial is testing

CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML

Who this might be right for
Myelodysplastic SyndromesSecondary Acute Myeloid Leukemia
H. Lee Moffitt Cancer Center and Research Institute 19
Early research (Phase 1)Study completedNCT00374933
What this trial is testing

Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05226455
What this trial is testing

Venetoclax in Patients With MDS or AML in Relapse After AHSCT

Who this might be right for
MDSAML
Groupe Francophone des Myelodysplasies 55
Not applicableStudy completedNCT00167167
What this trial is testing

Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia

Who this might be right for
Leukemia, Myeloid, ChronicAMLMDS+1 more
Masonic Cancer Center, University of Minnesota 40
Testing effectiveness (Phase 2)Study completedNCT01386619
What this trial is testing

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes+3 more
University Hospital, Basel, Switzerland 15
Large-scale testing (Phase 3)UnknownNCT03662087
What this trial is testing

HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT

Who this might be right for
Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation
Nanfang Hospital, Southern Medical University 100
Testing effectiveness (Phase 2)Study completedNCT02472691
What this trial is testing

Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Heinrich-Heine University, Duesseldorf 50
Not applicableStudy completedNCT00997529
What this trial is testing

Mini Allo Stem Cell Transplantation for the Treatment of Solid Tumors

Who this might be right for
Metastatic Solid Tumor
Beth Israel Deaconess Medical Center 14
Testing effectiveness (Phase 2)UnknownNCT01758367
What this trial is testing

Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation

Who this might be right for
Recurrent Adult Acute Myeloid Leukemia
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00984165
What this trial is testing

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hodgkin's LymphomaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemias+1 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Ended earlyNCT05447663
What this trial is testing

Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Stem Cell Transplantation
Novartis Pharmaceuticals 8
Early research (Phase 1)Study completedNCT00003243
What this trial is testing

Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT01025778
What this trial is testing

Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Lund University Hospital 7
Testing effectiveness (Phase 2)Study completedNCT00096161
What this trial is testing

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
Fred Hutchinson Cancer Center 36
Next Page